98 related articles for article (PubMed ID: 16548370)
1. [An effect of long-term cerebrolysin therapy in combination with neuroleptics on behavioral and cognitive disturbances in endogenous childhood autism].
Radzivil MG; Bashina VM
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):21-5. PubMed ID: 16548370
[TBL] [Abstract][Full Text] [Related]
2. [Use of cholinomimetics in the treatment of endogenous autism in children].
Krasnoperova MG; Simashkova NV; Bashina VM
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):35-9. PubMed ID: 15285632
[TBL] [Abstract][Full Text] [Related]
3. [The effect of cerebrolysin on cognitive functions in childhood autism and in Asperger syndrome].
Krasnoperova MG; Bashina VM; Skvortsov IA; Simashkova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(6):15-8. PubMed ID: 12872620
[TBL] [Abstract][Full Text] [Related]
4. [The efficacy of cerebrolysin in the treatment of autism spectrum disorders].
Chutko LS; Yakovenko EA; Surushkina SY; Kryukova EM; Palaieva SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):71-75. PubMed ID: 29053124
[TBL] [Abstract][Full Text] [Related]
5. [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].
Vereshchagin NV; Suslina ZA; Timerbaeva SL; Kashina EM; Gnezditskiĭ VV; Maksimova MIu; Rebrova OIu; Smirnova IN
Ter Arkh; 2001; 73(4):22-7. PubMed ID: 11494441
[TBL] [Abstract][Full Text] [Related]
6. [The effect of cerebrolysin on moderate cognitive impairment in cerebral vascular insufficiency (a clinical and electrophysiological study)].
Damulin IV; Koberskaia NN; Mkhitarian EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(5):32-8. PubMed ID: 18379494
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
[TBL] [Abstract][Full Text] [Related]
8. [The influence of cerebrolysin on the efficiency of subsequent therapy with amiridine++ in Alzheimer's disease patients (neuropsychological investigation)].
Roshchina IF; Kolykhalov IV; Selezneva ND; Zharikov GA; Gerasimov NP; Gavrilova SI
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):43-6. PubMed ID: 10629930
[TBL] [Abstract][Full Text] [Related]
9. [The therapeutic potential of cerebrolysin in the preventive therapy of Alzheimer's disease].
Gavrilova SI; Fedorova IaB; Kolykhalov IV; Odinak MM; Emelin AIu; Kashin AV; Selezneva ND; Kalyn IaB; Roshchina IF
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):24-8. PubMed ID: 18833104
[TBL] [Abstract][Full Text] [Related]
10. [Neuropsychological evaluation of long-term therapy of Alzheimer's disease using different cerebrolysin dosages].
Roshchina IF; Gavrilova SI; Zharikov GA; Kalyn IaB; Kolykhalov IV; Selezneva ND
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):52-5. PubMed ID: 15704485
[TBL] [Abstract][Full Text] [Related]
11. [Cerebrolysin treatment of mild cognitive impairment of vascular genesis].
Damulin IV; Mkhitarian EA; Koberskaia NN
Ter Arkh; 2007; 79(6):65-9. PubMed ID: 17684971
[TBL] [Abstract][Full Text] [Related]
12. [Use of cerebrolysin in the treatment of prolonged extrapyramidal complications of neuroleptic therapy].
Kontsevoĭ VA; Medvedev AV; Andrusenko MP; Zvenigorodskaia IuV; Sheshenin VS
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):39-44. PubMed ID: 11517474
[TBL] [Abstract][Full Text] [Related]
13. [The pathophysiological analysis of cerebrolysin therapy of children with mental developmental delay caused by ecological factors].
Govorin NV; Zlova TP; Akhmetova VV; Tarasova OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(5):51-5. PubMed ID: 18577958
[TBL] [Abstract][Full Text] [Related]
14. Are abilities abnormally interdependent in children with autism?
Dyck MJ; Piek JP; Hay D; Smith L; Hallmayer J
J Clin Child Adolesc Psychol; 2006 Feb; 35(1):20-33. PubMed ID: 16390300
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial.
Muresanu DF; Florian S; Hömberg V; Matula C; von Steinbüchel N; Vos PE; von Wild K; Birle C; Muresanu I; Slavoaca D; Rosu OV; Strilciuc S; Vester J
Neurol Sci; 2020 May; 41(5):1171-1181. PubMed ID: 31897941
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
Ladurner G; Kalvach P; Moessler H;
J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
[TBL] [Abstract][Full Text] [Related]
17. A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease.
Alvarez XA; Cacabelos R; Laredo M; Couceiro V; Sampedro C; Varela M; Corzo L; Fernandez-Novoa L; Vargas M; Aleixandre M; Linares C; Granizo E; Muresanu D; Moessler H
Eur J Neurol; 2006 Jan; 13(1):43-54. PubMed ID: 16420392
[TBL] [Abstract][Full Text] [Related]
18. Atypical behaviors in children with autism and children with a history of language impairment.
Dominick KC; Davis NO; Lainhart J; Tager-Flusberg H; Folstein S
Res Dev Disabil; 2007; 28(2):145-62. PubMed ID: 16581226
[TBL] [Abstract][Full Text] [Related]
19. [Cognitive processing in autism spectrum disorders].
Idiazábal-Aletxa MA; Boque-Hermida E
Rev Neurol; 2007 Mar; 44 Suppl 2():S49-51. PubMed ID: 17347945
[TBL] [Abstract][Full Text] [Related]
20. [Cerebrolysin in the treatment of brain injuries of moderate severity].
Talypov AE; Myachin MY; Kuksova NS; Kordonsky AY
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):98-106. PubMed ID: 25591645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
